Search For "glenmark pharmaceuticals"
Glenmark Pharmaceuticals receives ANDA tentative approval for Regadenoson
Updated : 4 years, 2 months ago IST
Mumbai (Maharashtra) [India], January 17 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc., USA (Glenmark) has received tentative approval by the United States Food & Drug Administration (U.S. FDA) for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single-Dose Pre-Filled Syringe, the g
Read More
Glenmark's subsidiary receives NDA Approval by US FDA for Ryaltris™
Updated : 4 years, 2 months ago IST
Mumbai (Maharashtra) [India], January 14 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company announced that its fully owned subsidiary Glenmark Specialty S.A. (Switzerland), received FDA approval on its New Drug Application (NDA) fo
Read More
Glenmark Pharmaceuticals makes it to the prestigious Dow Jones Sustainabil
Updated : 4 years, 4 months ago IST
Mumbai (Maharashtra) [India], November 16 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that the company has been listed in the Dow Jones Sustainability Index (DJSI), under the category of emerging markets
Read More
Glenmark Pharma reports revenue growth of 6.6% and PAT growth of 10.1% YoY
Updated : 4 years, 4 months ago IST
Mumbai (Maharashtra) [India], November 13 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical company, today announced its financial results for the second quarter ended Sept 30, 2021.
Read More
Glenmark becomes the first company to launch Remogliflozin + Vildagliptin
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], October 26 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed-dose combination (FDC) of its novel, patent-protected, globally researched Sodium-Glucose Co-Transporter Inhibitor (SGLT2i
Read More
Glenmark Pharmaceuticals launches fixed-drug combination for management of
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], October 26 (ANI): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed drug combination for the management of type 2 diabetes.
Read More
Glenmark launches Tavulus® for COPD treatment in Spain
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], October 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company today announced the launch of a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name Tavulus® in Spa
Read More
Glenmark receives marketing approval for Ryaltris®, an innovative com
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], September 30 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, has received marketing approval for its fixed-dose combination nasal spray Ryaltris® in 13 countries across the EU and UK.
Read More
Glenmark receives marketing approval for Ryaltris in 13 countries across E
Updated : 4 years, 5 months ago IST
New Delhi [India] September 30 (ANI): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, has received marketing approval for its fixed-dose combination nasal spray Ryaltris in 13 countries across the EU and UK.
Read More
Apposite wins the coveted Brandon Hall Group Silver Award for excellence i
Updated : 4 years, 6 months ago IST
Hyderabad (Telangana) [India], September 21 (ANI/BusinessWire India): Apposite Learning Solutions, a Hyderabad-based organization is renowned for creating innovative learning solutions for premier clients such as Microsoft, Coromandel, Glenmark Pharmaceuticals, among many others.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate
Updated : 4 years, 6 months ago IST
Mumbai (Maharashtra) [India], September 21 (ANI/PR Newswire): Glenmark Pharmaceuticals Ltd. (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Clindamycin Phosphate Foam, 1%, the generic version of Evoclin®1 Foam, 1%, of Mylan Pharm
Read More
Glenmark concludes post marketing surveillance (PMS) study on Favipiravir
Updated : 4 years, 6 months ago IST
Mumbai (Maharashtra) [India], September 15 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced the successful completion of its Post Marketing Surveillance (PMS) study on Favipiravir (FabiFlu®) in India.
Read More